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EVIDENCE FOR RADIATION HORMESIS AFTER IN VITRO EXPOSURE OF
HUMAN LYMPHOCYTES TO LOW DOSES OF IONIZING RADIATION§
Kanokporn Noy Rithidech  Pathology Department, Stony Brook University,
Stony Brook, NY
Bobby R. Scott  Lovelace Respiratory Research Institute, Albuquerque, NM
 Previous research has demonstrated that adding a very small gamma-ray dose to a
small alpha radiation dose can completely suppress lung cancer induction by alpha radia-
tion (a gamma-ray hormetic effect). Here we investigated the possibility of gamma-ray
hormesis during low-dose neutron irradiation, since a small contribution to the total radi-
ation dose from neutrons involves gamma rays. Using binucleated cells with micronuclei
(micronucleated cells) among in vitro monoenergetic-neutron-irradiated human lympho-
cytes as a measure of residual damage, we investigated the influence of the small gamma-
ray contribution to the dose on suppressing residual damage. We used residual damage
data from previous experiments that involved neutrons with five different energies (0.22-,
0.44-, 1.5-, 5.9-, and 13.7-million electron volts [MeV]). Corresponding gamma-ray contri-
butions to the dose were approximately 1%, 1%, 2%, 6%, and 6%, respectively. Total
absorbed radiation doses were 0, 10, 50, and 100 mGy for each neutron source. We
demonstrate for the first time a protective effect (reduced residual damage) of the small
gamma-ray contribution to the neutron dose. Using similar data for exposure to gamma
rays only, we also demonstrate a protective effect of 10 mGy (but not 50 or 100 mGy) relat-
ed to reducing the frequency of micronucleated cells to below the spontaneous level.
Keywords: Gamma rays, X rays, Neutrons, Hormesis, Human Lymphocytes, Micronucleus
1. INTRODUCTION
There is no doubt that high doses of radiation are hazardous to cells
and tissues. However, using varying biological endpoints (e.g., chromoso-
mal damage, mutations, neoplastic transformation, and cancer), benefi-
cial (not detrimental) effects of exposure to low doses of radiation have
been found (Luckey 1982; Shadley and Wolff 1987; Bond et al. 1991;
Luckey 1991; Cohen 1995; Azzam et al. 1996; Mitchel et al. 1999;
Calabrese and Baldwin 2000; Hooker et al. 2004; Elmore et al. 2005;
Feinendegen 2005; Day et al. 2006; Tubiana et al. 2006; Feinendegen et
al. 2007). Nonetheless, information on such benefits is mainly limited to
low doses of low linear-energy-transfer (LET) photons (i.e., X and γ rays)
or combinations of low-LET gamma and high-LET alpha radiation (Scott
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and Di Palma 2006; Sanders and Scott 2008; Scott et al. 2008; Scott,
2008a,b). A large number of people are at risk of exposure to neutrons
worldwide. For example, during 1988 it was estimated that approximate-
ly 7,000 people per year in the facilities of the Department of Energy
(DOE) and about 6,000 research workers, including well loggers and
reactor workers, were exposed to neutrons (Miller et al., 1999).
Additionally, airline crew members and astronauts are at high risk of
exposure to neutrons during space flights (Wilson and Townsend 1988). 
Neutron interactions with matter involve absorption reactions. In a
neutron absorption reaction the incident neutron is absorbed into the
nucleus of an atom. Secondary radiations emerge with energies that
depend on the intermediate excited nuclear configuration. The second-
aries may be gamma rays from radioactive capture reactions (n, γ) and
they can be nuclear-derived particles including protons, neutrons, or
other heavier ions. The small low-LET gamma-ray contribution to the
dose might cause radiation hormesis (i.e., adaptive response) with
respect to reducing the harm associated with the other larger compo-
nents to the total radiation dose, as has been demonstrated for combined
alpha and gamma irradiation (Sanders 2007). Gamma-ray doses of 1 to 2
mGy appeared to completely prevent lung cancer induction in Wistar rats
after inhaling the alpha emitter 239Pu in an insoluble dioxide form, for
alpha radiation doses up to about 600 mGy (Sanders 2007; Scott et al.
2008; Scott 2008a). Spontaneous lung cancers also appeared to be pre-
vented. The possibility that similar protective effect may occur during
neutron irradiation has not previously been investigated. 
To improve low-dose health risk assessment and biological dosimetry
for neutron exposures, it is important to determine when hormetic
effects from the gamma-ray contribution to the dose would be expected
to occur. In this study of radiation-induced residual damage, as measured
by micronucleated cells among irradiated human lymphocytes, we looked
for evidence of hormetic effects (reduced micronucleated cells) of very
small gamma-ray contributions to the total radiation dose from neutron
irradiation. Micronucleus (MN) data from previous experimental studies
of Rithidech (Rithidech et al., 1990) using neutron sources of different
energies and varying gamma-ray contributions to the dose are reevaluat-
ed here in the context of gamma-radiation hormesis. 
We also looked for evidence for photon radiation hormesis related to
low-dose X- and gamma-ray suppression of cells with spontaneous chro-
mosomal damage (presumably via apoptotic removal). The radiations
studied were: (a) photons, i.e., 662-keV gamma rays, 70-kVp X rays, and
250-kVp X rays; and (b) monoenergetic neutrons, i.e., 0.22-, 0.44-, 1.5-,
5.9-, and 13.7- MeV. For the monoenegetic neutrons, the gamma-ray con-
tributions to the total radiation dose were 1 %, 1%, 2%, 6%, and 6%,
respectively (Table 1). Corresponding contributions from other compo-
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nents to the dose (protons, neutrons, other ions) were 99%, 99%, 98%,
94%, and 94% respectively. Cells with residual chromosomal damage
(assayed by the presence of MN in binucleated human lymphocytes fol-
lowing irradiation in vitro) were used as a biological endpoint for deter-
mining hormetic effects of low doses of radiation. Two types of dosimet-
ric variables were used: (a) absorbed radiation dose, and (b) average radi-
ation microdose to nuclear-size volumes (NSV) due to single events. The
indicated microdose is indicated here by <z1> and has been used by oth-
ers in microdosimetric modeling of radiation hormesis (Feinendegen
2005). The symbol z represents specific energy (stochastic microscopic
dose). The subscript 1 is used to specify that the microdose of interest
relates to a single hit to each biological micromass of interest (e.g., cell,
cell nucleus, etc.). The average value for the microscopic dose z equals
the macroscopic absorbed dose D. The average number of hits to NSV is
given by the ratio D/<z1>.
It has been well recognized that an analysis of chromosomal damage
in metaphase cells prepared from peripheral blood lymphocytes stimu-
lated to proliferate in vitro is one of the most reliable assays for detecting
genomic damage from either low- or high-LET radiation, under various
conditions (Lloyd and Edwards 1983; Bender et al. 1988). However, meas-
uring chromosomal damage in metaphase cells is expensive and labor
intensive; therefore, the MN assay is used as an alternative because of its
simplicity and the speed by which cells can be scored. Scoring of a larger
number of cells results in increased statistical power to detect even slight
yet important differences among groups because the greater number of
observations facilitates an enhanced statistical analysis. The MN assay is
also possibly applicable to automation analysis (Tates et al. 1990).
Development of the cytokinesis-block micronucleus (CBMN) assay
(Fenech and Morley, 1985) has greatly improved the usefulness of the
MN method. In this assay, cytochalasin B (Cyt-B) disrupts cytokinesis pre-
venting daughter cells from separating. This disruption results in the for-
mation of binucleated cells. With this method, the scoring of MN can be
TABLE 1. Typical RARAF neutron energy and secondary gamma-ray characteristicsa
Neutron energy (MeV) 
and spread (± %) γ-ray dose (%) Production reaction
0.22 (25) 1 T(p,n)3He
0.44 (14) 1 T(p,n)3He
1.5 (10) 2 T(p,n)3He
5.9(6) 6 D(d,n)3He
13.7 (1) 6 T(d,n)4He
aT, tritium; D, deteriuim; p, proton; n, neutron; d, deuteron 
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confined to cells that have undergone one cell division following the
exposure, i.e. binucleated cells. Based upon these reasons, the MN assay
was selected as a biological endpoint for evaluating the hormetic effects
of low dose radiation.
It is known that MN can arise from acentric fragments (kinetochore-
negative MN) or lagging whole chromosomes (kinetochore-positive MN)
which are not incorporated into daughter nuclei at the time of cell divi-
sion. Thus, MN reflect not only clastogenicity, but also spindle fiber dis-
ruption by genotoxic agents. Some existing evidence demonstrates that
radiation-induced MN are mainly derived from acentric fragments
(Heddle and Carrano 1977; Littlefield et al. 1989). On the other hand,
substantial data show that radiation can cause kinetochore-positive MN
(Eastmond and Tucker 1989; Fenech and Morley 1989; Cornforth and
Goodwin 1991). The intercellular distribution of MN has been reported
to be Poisson (Ramalho et al. 1988; Littlefield et al. 1989) or hyper-
Poisson (Prosser et al. 1988), or over-dispersed (Hoffmann et al. 1993;
Vral et al. 1994), depending on the radiation dose. While the frequencies
of MN and acentric fragments increasingly diverge at doses of sparsely
ionizing radiation above 1 Gy, it appears that at low doses of this type of
radiation virtually all acentric fragments can be recovered as MN
(Ramalho et al. 1988; Littlefield et al. 1989; Vral et al. 1994).
Using the CBMN method, a number of studies have been conducted
in human lymphocytes to investigate the induction of MN by radiation
and to compare MN data with data on metaphase chromosome-aberra-
tion induction (Almassy et al. 1987; Mitchell and Norman 1987; Kormos
and Koteles 1988; Prosser et al. 1988; Littlefield et al. 1989; Balasem and
Ali 1991; Vral et al. 1998). Although the induction of chromosome aber-
rations (determined by metaphase assay) in human peripheral blood lym-
phocytes by high-LET radiation (particularly neutrons) has been estab-
lished, not much information exists on MN induction among exposed
human lymphocytes. Published data demonstrate a linear dose-response
for MN induction in human lymphocytes by high doses of fission neu-
trons (250 to 1500 mGy) (Ban et al. 1991) and for fast neutron irradia-
tion (60 to 1000 mGy) of mouse zygotes (Pampfer et al. 1992). Our study
is the first to focus on lower doses (10 to 100 mGy) where hormetic effects
related to the gamma-ray contribution to the dose may occur. We are not
aware of any previous publication where hormesis has been reported in
relationship to neutron irradiation of cells in culture. This paper provides
the first such reporting and demonstrates hormesis in relation to the
gamma-ray component of the dose.
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2. MATERIALS AND METHODS
Blood Sample Collection 
Peripheral blood samples (approximately 5 mL) were collected by
venipuncture into heparinized syringes from five nonsmoking healthy
male volunteers (age ranging from 40-45 years old) using established
blood-borne pathogen/biohazard safety protocols. These volunteers had
no known history of previous exposure to clastogenic agents. This study
was conducted under the approval of the Institutional Review Board of
Brookhaven National Laboratory. After collection, blood samples were
kept at room temperature until irradiation. Whole blood samples were
irradiated before culture initiation. 
Irradiation Procedures
X-ray exposures of blood samples were done at the Medical
Department, Brookhaven National Laboratory (BNL), Upton, New York,
using a dose rate of 0.3 Gy/min. Gamma-ray exposures were done at the
Controlled Environment Radiation Facility of the Biology Department,
BNL, using a dose rate of 0.5 Gy/min. For exposures to “monoenergetic”
fast neutrons (high-LET radiation), whole blood samples were transport-
ed at room temperature (in a temperature controlled vehicle) to the
Radiological Accelerator Facility (RARAF) of Columbia University, New
York. The device produces essentially monoenergetic neutrons of various
mean energies. Those selected were: 0.22-, 0.44-, 1.5-, 5.9-, and 13.7-MeV.
Dose rates ranged from 0.05 to 0.6 Gy/hr, as described previously (Bond
et al. 1997). Table 1 shows typical RARAF neutron energies and second-
ary gamma-ray characteristics. Irradiation was done at room temperature
in a controlled area for both types of radiation. Due to the time needed
for transportation of blood samples to and from RARAF, the irradiation
of whole blood samples was performed at 4 hours after blood drawing. To
be consistent, this schedule was also applied to X- and gamma-irradiation
at BNL. Subsequently, irradiated whole blood samples were kept at room
temperature for another 4 hours before the initiation of cultures. Overall,
culture initiation of all blood samples was done within 8 hours after blood
drawing. 
Culture Methodology
The condition of blood lymphocyte cultures was similar to that rou-
tinely used in our laboratory (Rithidech et al. 2005), except that whole
blood, not isolated lymphocytes, was used in this study. To do this, 1 mL
of whole blood was added to a 15-mL conical tube containing 9 mL of
RPMI 1640 medium, supplemented with 15% heat-inactivated fetal
bovine serum, 1% glutamine, 1% pennicillin/streptomycin, and
5
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5 μg/mL phytohemagglutinin (PHA). Cells were incubated at 37°C in
humidified 5% CO2 atmosphere. Two samples from each volunteer were
irradiated at each dose and the experiments were duplicated. In each
experiment, there were 4 culture tubes per dose for all treatments. The
protocol for the CBMN developed by Fenech and Morley (Fenech and
Morley 1985) was followed. A detailed protocol of the CBMN assay has
been presented elsewhere (Fenech 2007). Briefly, at 44 hours after cul-
ture initiation, Cytochalasin-B (Cyt-B) was added to each culture tube,
resulting in a final concentration of 3 μg/mL, to block cytokinesis (which
normally occurs in the telophase phase of the cell cycle). Cells were har-
vested 28 hours after the addition of Cyt-B. The total culture time was 72
hours which resulted in the formation of many first division binucleated
cells (35-60% or more binucleated cells as a proportion of viable cells, i.e.
all cells excluding necrotic and apoptotic cells) that were scored for the
induction of MN (Albertini et al. 2000; Fenech 2000). Although the MN
assay can also provide information on apoptotic cells [i.e. cells with chro-
matin condensation within the nucleus and intact cytoplasmic and
nuclear boundaries; and cells exhibiting nuclear fragmentation into
smaller nuclear bodies within an intact cytoplasmic membrane (Fenech
et al. 2003)], the scope of this study was to score the occurrence of MN in
binucleated cells only.
Micronucleus Analysis
Basically, the method routinely used in our laboratory (Rithidech et
al. 2005) was applied. Briefly, at the harvest time, after centrifugation at
1,500 rpm for 5 min, cell pellets were treated with 5 ml of a solution con-
taining 1:1 v/v MilliQ water:RPMI 1640 medium (mild hypotonic solu-
tion) for 3 minutes. After another centrifugation, cells were washed twice
with the fixative solution (3:1 v/v methanol:acetic acid). Fixed cells were
dropped gently on clean microscope slides, air-dried and stained with
10% Gurr Giemsa (BDH, Santa Monica, CA) for 8 minutes. The slides
were coded before scoring. Only binucleated cells with well-preserved
cytoplasm were scored for MN (under a light microscope with a 40 × 10
magnification). The criteria for selection of binucleated cells and identi-
fication of MN given in the HUMN project website [http://HUMN.org]
were followed. In brief, cells having two distinct nuclei of approximately
equal size, which may be attached by a fine nucleoplasmic bridge or over-
lap slightly or touch each other at the edges, were selected. The number
of MN (with the size varying from 1/16 to 1/3 of the mean diameter of
the main nuclei) located within the cytoplasm of a binucleated cell was
scored and recorded. The numbers of binucleated cells with one, two,
three or more MN were then tabulated. 
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Evaluating Group Differences in the Number of Micronucleated Cells
Significant differences between the numbers of micronucleated cells
(one or more MN) between a selected reference group and another com-
parison (irradiated) group were evaluated based on a 1 degree of freedom
(df) chi-square test. Both an unirradiated control and an irradiated group
were used as references but for different analyses. Expected numbers of
micronucleated cells for the comparison group (irradiated group in each
case) were evaluated based on the frequency of micronucleated cells
among the reference group. In some cases the study-matched controls were
used as reference. In other cases study-specific control data were combined
to increase sample size. This was done to increase power for demonstrating
a radiation-related reduction in the MN frequency to below the sponta-
neous level (which was quite small and fluctuated between studies). 
Data for low-energy neutrons were also used as a reference when look-
ing for a protective effect of the very small, gamma-ray component to the
neutron dose. For these analyses data for 0.22-MeV and 0.44-MeV neu-
trons which have similar interaction characteristics (i.e., similar micro-
doses to NSV and the same gamma-ray contribution [approximately 1%]
to the total dose) and similar relative biological effectiveness [RBE;
(Miller et al. 1999)] were combined to comprise a single reference group.
Confidence Interval for the Proportion of Micronucleated Cells
The binomial parameter φ as used here represents the true propor-
tion of micronucleated cells among a large population of n surviving irra-
diated human lymphocytes. We use an unbiased point estimate of φ given
by ρ = M/N, where M is the presumably binomially distributed observed
number of residual micronucleated cells among samples of N cells
scored. Our 95% interval estimate of φ is based on the normal distribu-
tion approximation to the binomial distribution (Fleiss 1981; Rosner
2000) which yields the approximate 100% × (1 – α) confidence interval ρ
± Z1–α/2 [ρ(1 – ρ)/N]1/2, where Z is the standardized normal distribution
and α = 0.05. The normal approximation is considered valid so long as
Nρ(1 – ρ) ≥ 5 (Rosner 2000), which is the case for all of the data used in
this paper.
Significant Differences Between ρ for Controls and Irradiated Groups
Significant increases and reduction in ρ after radiation exposure rel-
ative to a reference level ρ* (based on the group-specific proportion for
pooled controls) were evaluated as follows:
When there is an apparent increase, i.e. ρ > ρ*:
p – value = 
p*∫
–∞
Φ(x, ρ, ρ(1 – ρ)/N)dx
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When there is an apparent decrease, i.e. ρ < ρ*:
p – value = 
∞∫
p*
Φ(x, ρ, ρ(1 – ρ)/N)dx
In the above two equations, Φ is the normal probability density
function evaluated at proportion x when the distribution has mean pro-
portion ρ and variance ρ(1 - ρ)/N. These relationships arise based on the
normal distribution approximation to the binomial distribution for M,
conditional on N.
Estimation of the Gamma-Ray Protection Factor
When evaluating the possible suppression of neutron-induced resid-
ual damage via gamma-ray hormesis it is beneficial to evaluate the pro-
tection factor [PROFAC; (Scott and Di Palma 2006)] which here repre-
sents the expected proportion of micronucleated cells prevented due to
protective processes associated with radiation hormesis. These protective
processes are thought to include induced high fidelity repair of DNA
damage and selective apoptosis that removes damaged cells (Scott and Di
Palma 2006; Portess et al. 2007). The PROFAC was evaluated as 1 –
[(observed micronucleated cells)/(expected micronucleated cells)]. The
expected frequency of micronucleated cells was evaluated based on a ref-
erence group comprised of data for 0.22- and 0.44-MeV neutrons. This
frequency was multiplied by the number of cells scored in the compari-
son group (1.5- or 5.9- or 13.7-MeV neutrons).
A dose-response relationship for the PROFAC was constructed using
<z1> as the independent variable. We show later that as <z1> increases,
PROFAC decreases. The decrease may relate to deleterious bystander
effects of nuclear hits by high-LET events that suppress protective signal-
ing associated with hormesis (Scott and Di Palma 2006). For demonstrat-
ing suppression of protection against residual biological damage (i.e.,
decreases in PROFAC), we therefore have used <z1> evaluated based on
NSV rather than cell-size volumes. However, for low-LET irradiation, pro-
tective bystander effects are also important and may involve volumes
much larger than that for a single cell since ultra low X-ray doses that hit
only a small number of cells at risk (but more than one cell) can induce
protective signaling (Day et al. 2006, 2007). Thus, for developing a com-
plete theory of radiobiological effects, two levels of dosimetry may be
required, microdosimetry (for suppression of protective signaling) and
macrodosimetry (for stimulation of protective signaling). We speculate
that the suppressive microdosimetric effect may relate to deficient cell
nucleus to mitochondria signaling, leading to a loss of one or more key
pathways associated with protective apoptosis (Bauer 2007; Portess et al.
2007) that eliminates aberrant cells. In circumstances where mainly pro-
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tective bystander effects occur, absorbed dose would therefore be expect-
ed to be more relevant than average hits to NSV. 
Estimation of <z1> for Different Radiations of Interest
The dose reflects the corresponding 1-hit dose to the cell nucleus.
However, it also reflects the 1-hit dose to any other volume of the same
size within the cell (e.g., equivalent volume within the cytoplasm). The
indicated average hit depends on the volume of the biological micro-
masses considered (here all volumes in the irradiated target are the size
of the cell nucleus). When estimated for a given radiation source and bio-
logical micromass, <z1> can then be scaled by LET (Leonard, 2007) or by
values obtained for 1 μm size spherical biological micromasses as are
reported in the BEIR IV Report (NAS/NRC 1988). This is the approach
we used to obtain results presented in Table 2 with 250-kVp X rays being
used as reference. Leonard (2007) reported the value <z1> = 2 mGy/hit for
250-kVp X irradiation of human lymphocytes based on data from Pohl-
Rüling et al. (Pohl-Ruling et al. 1983). Values of LET used in scaling were
obtained from NCRP Report 104 (NCRP 1990). 
When the probability of damage occurrence is expressed as a func-
tion of z1 (the actual hit size), the resultant dose-response curve is called
a hit-size effectiveness function (Bond et al. 1995; Sondhaus et al. 1996).
Such functions in theory could be used to explain the different effective-
ness of different radiation in producing biological damage to cells.
Whether or not this is feasible can be evaluated on the basis of biological
damage correlating with <z1>. Later we use the relative frequency of
micronucleated cells (for one or more MN per cell) evaluated at a fixed
low dose (10 mGy) and evaluated relative to 250-kVp X rays to test for a
significant correlation of biological damage with <z1>. 
TABLE 2. The value of <z1> for each type of radiation
Radiation <z1> Scaling Based On
137Cs gamma rays 0.64 mGy/hit 1-μm sphere
70-kVp X rays 3.6 mGy/hit 1-μm sphere
250-kVp X rays 2.0 mGy/hit No scaling
13.7-MeV neutrons 20.0 mGy/hit 1-μm sphere
5.9-MeV neutrons 54.0 mGy/hit LET
1.5-MeV neutrons 64.0 mGy/hit LET
0.44-MeV neutrons 80.0 mGy/hit 1-μm sphere
0.22-MeV neutrons 94.0 mGy/hit LET
9
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3. RESULTS AND DISCUSSION
The frequency and distribution of MN in human lymphocytes
induced by various doses of low- and high-LET radiation are shown in
Table 3. Table 4 shows results of comparing irradiated groups relative to
study-matched controls to see if there is any evidence for hormesis or for
an increase in risk. All doses above 10 mGy demonstrated significant
increases in the frequency of micronucleated cells. None of the 10-mGy
data showed a significant hormetic effect. The control data were then
combined (total cells = 79,950) to look for a possible significant suppres-
TABLE 3. Frequency and distribution of micronuclei in binucleated human lymphocytes according
to radiation type and dose (* Numbers in parentheses are nuclei per cell)
Total Total Mean micronuclei Micronuclei
Radiation Energy Dose cells micronuclei per 1000 cells distribution/cell
(mGy) scored frequency ± S.E.
0 1 2 3 >3*
Neutron 0.22-MeV 0 12,019 153 13.52 ± 4.53 11,876 131 11 0 1(4)
10 8,882 150 16.27 ± 4.57 8,757 107 16 1 1(7)
50 8,658 185 23.09 ± 5.29 8,491 149 15 2 1(4)
100 11,744 386 30.75 ± 6.63 11,564 275 56 3 0
Neutron 0.44-MeV 0 13,680 74 6.25 ± 1.44 13,606 74 0 0 0
10 12,027 93 9.01 ± 4.02 11,838 82 4 1 0
50 11,964 182 16.75 ± 2.84 11,802 160 2 0 0
100 9,625 278 33.50 ± 5.95 9,376 227 21 3 0
Neutron 1.5-MeV 0 9,060 42 4.45 ± 1.20 9,018 42 0 0 0
10 9,769 64 6.24 ± 1.05 9,709 56 4 0 0
50 9,827 116 11.21 ± 2.11 9,727 84 15 0 0
100 9,873 176 16.71 ± 2.43 9,717 149 12 1 0
Neutron 5.9-MeV 0 10,942 48 4.35 ± 2.16 10,896 44 2 0 0
10 13,730 105 6.24 ± 2.36 13,631 93 6 0 0
50 12,787 151 9.64 ± 2.57 12,649 125 13 0 1(8)
100 10,526 178 13.80 ± 3.15 10,364 144 18 0 0
Neutron 13.7-MeV 0 11,025 26 1.18 ± 0.76 11,001 22 2 0 0
10 9,833 40 3.98 ± 0.97 9,794 38 1 0 0
50 8,150 44 5.53 ± 0.75 8,110 36 4 0 0
100 9,997 102 10.31 ± 1.18 9,904 84 9 0 0
X rays 70-kVp 0 9,256 57 5.51 ± 1.97 9,201 53 2 0 0
10 7,549 44 5.57 ± 1.74 7,505 44 0 0 0
50 8,826 85 9.17 ± 1.24 8,747 72 5 0 0
100 6,683 102 12.75 ± 0.39 6,585 94 4 0 0
X rays 250-kVp 0 6,069 57 9.35 ± 0.06 6,046 44 5 1 0
10 10,263 86 8.43 ± 0.20 10,184 72 7 0 0
50 7,915 85 10.72 ± 1.24 7,837 74 1 3 0
100 5,080 77 15.09 ± 0.44 5,007 70 2 1 0
γ rays 662-keV 0 7,899 19 2.39 ± 0.17 7,881 17 1 0 0
10 7,716 23 2.96 ± 0.55 7,695 19 2 0 0
50 6,047 28 4.22 ± 1.18 6,020 26 1 0 0
100 6,705 42 6.25 ± 0.11 6,664 40 1 0 0
10
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sion in the frequency of micronucleated cells after irradiation. Only the
10-mGy data for gamma-ray exposure was found to be significantly sup-
pressed (p = 1.73 × 10–3).
TABLE 4. Test for significant differences between study-specific controls and irradiated groups for
the number of micronucleated cells among human lymphocytes evaluated by radiation type and
dose level
Cells Observed Expected Significant
Dose Total Without Micronucleated Micronucleated Chi Hormetic
mGy Cells Micronuclei Cells Cells Square p-value Effect
Neutron, 0.22-MeV
0 79950 79525 425 425
10 8882 8757 125 47.2 128.8 7.38E–30 no
50 8658 8491 167 46.0 319.7 1.70E–71 no
100 11744 11564 180 62.4 222.6 2.45E–50 no
Neutron, 0.44-MeV
0 79950 79525 425 425.0
10 12027 11838 189 63.9 246 1.97E–55 no
50 11964 11802 162 63.6 153 3.71E–35 no
100 9625 9376 249 51.2 769 2.9E–169 no
Neutron, 1.5-MeV
0 79950 79525 425 425.0
10 9769 9709 60 51.9 1.3 2.62E–01 no
50 9827 9727 100 52.2 43.9 3.45E–11 no
100 9873 9717 156 52.5 205 1.48E–46 no
Neutron, 5.9-MeV
0 79950 79525 425 425.0
10 13730 13631 99 73.0 9.3 0.002265 no
50 12787 12649 138 68.0 73 1.65E–17 no
100 10526 10364 162 56.0 202 7.44E–46 no
Neutron, 13.7-MeV
0 79950 79525 425 425.0
10 9833 9794 39 52.3 3.4 6.57E–02 suggested
50 8150 8110 40 43.3 0.3 0.612613 no
100 9997 9904 93 53.1 30 4.2E–08 no
X Rays, 70-kVp
0 79950 79525 425 425.0
10 7549 7505 44 40.1 0.375 5.40E–01 no
50 8826 8747 79 46.9 22.1 2.65E–06 no
100 6683 6585 98 35.5 110.5 7.8E–26 no
X rays, 250-kVp
0 79950 79525 425 425.0
10 10263 10184 79 54.6 11.0 0.000906 no
50 7915 7837 78 42.1 30.8 2.8E–08 no
100 5080 5007 73 27.0 79 7.01E–19 no
γ rays, 662-keV
0 79950 79525 425 425.0
10 7716 7695 21 41.0 9.82 1.73E–03 yes
50 6047 6020 27 32.1 0.8 3.63E–01 no
100 6705 6664 41 35.6 0.8 0.368247 no
11
Rithidech and Scott: Radiation hormesis in human lymphocytes
Published by ScholarWorks@UMass Amherst, 2014
Radiation hormesis in human lymphocytes
263
Dose-Response Curves
Figure 1 shows the resulting photon dose-response curves for the bio-
logical damage (frequency of one or more MN per cell) as a function of
the absorbed radiation dose for 70-kVp X rays, 250-kVp X rays, and 662-
keV gamma rays. The horizontal dashed lines comprise the 95% confi-
dence band for the combined control dataset. Ninety-five percent confi-
dence intervals for the data are also presented for the gamma-ray data but
are not presented for the X-ray data to avoid a cluttered presentation of
the results. The gamma-ray curve in Fig. 1 is J-shaped, which is charac-
teristic of hormetic responses (Calabrese and Baldwin 2000). We specu-
late that low doses can cause a mild stress response that leads to the elim-
ination of aberrant cells via protective apoptosis, as has been reported
elsewhere (Scott and Di Palma 2006; Portess et al. 2007). We further spec-
ulate that the critical volume for initiating the protective apoptosis by
gamma irradiation is larger than the size of the cell as has been implicat-
ed by results of studies conducted by Day et al. (Day et al. 2006, 2007)
where doses for which most cells were not hit led to protective signaling
that apparently eliminated aberrant (mutant) cells from the population.
The absence of hormetic responses for 70- and 250-kVp X rays was not
expected, given that such responses have been demonstrated for neo-
plastic transformation for similar photon radiation energies (Scott 2004;
Scott 2005). However, a key variable in addition to photon radiation ener-
FIGURE 1. Dose-response curves for the frequency of micronucleated cells after exposure of human
lymphocytes to photon radiations with different energy characteristics: Gamma rays (diamonds); 70-
kVp X rays (squares); 250-kVp X rays (triangles). Horizontal dashed lines indicated the 95% confi-
dence region for the pooled control data. Error bars for data points are 95% confidence intervals.
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gy is the absorbed dose rate. High rates can inhibit protective signaling
while low-rate extended exposure can efficiently stimulate protective sig-
naling and expand the dose range over which protective effects are
observed (Elmore et al. 2006; Scott and Di Palma 2006). 
Corresponding results for monoenergetic neutrons are presented in
Figure 2. No significant reduction (relative to controls) in the frequency
of micronucleated cells was found (p > 0.05) based on the chi-square test
related to observed and expected micronucleated cells. However, a sig-
nificant reduction was found for 13.7-MeV neutrons related to the com-
bined controls when based on a normal distribution with mean ρ and
variance ρ(1 – ρ)/N as explained in the Methods section. The horizontal
dashed lines in Figure 2 comprise the 95% confidence band for the com-
bined control data. Ninety-five percent confidence intervals are also
shown for the 13.7-MeV data. Confidence intervals for the other neutron
data were excluded to avoid a cluttered presentation of the results. 
Demonstration of Gamma-Ray Protection from Neutron-Induced Harm
Table 5 shows results obtained when the 0.22-MeV and 0.44-MeV neu-
tron data were combined and used as reference to see if there is evidence
for protection associated with the very small gamma-ray component to
the dose. The gamma-ray dose by itself is too small (< 10 mGy) to be
expected to cause any significant harm (see gamma-ray dose-response in
FIGURE 2. Dose-response curves for the frequency of micronucleated cells after exposure of human
lymphocytes to monoenergetic neutrons: 13.7-MeV (open circles); 1.5-MeV (triangles); 5.9-Mev
(closed circles); 0.44-MeV (squares); 0.22-MeV (diamonds). Horizontal dashed lines indicated the
95% confidence region for the pooled control data. Error bars for data points are 95% confidence
intervals.
13
Rithidech and Scott: Radiation hormesis in human lymphocytes
Published by ScholarWorks@UMass Amherst, 2014
Radiation hormesis in human lymphocytes
265
Figure 1). However, doses in the indicated range have been demonstrat-
ed to suppress alpha radiation-induced lung cancer (Sanders 2007). It
can be seen from Table 5 that adding a gamma-ray dose as low as 0.1 to
0.5 mGy, when the total radiation dose is 10 mGy, leads to PROFAC esti-
mates of 0.52 to 0.74 when evaluated relative to the low energy neutrons
(0.22- and 0.44-MeV data combined). This means that 52% to 74% of the
expected micronucleated cells did not occur as a result of gamma-ray
induced protection (gamma-ray hormesis). The average and standard
deviation for these estimates are 0.62 ± 0.11 and is clearly greater than
zero. For a total dose of 50 mGy, the corresponding PROFACs are 0.36,
0.32, and 0.69 respectively. The average and standard deviation for these
estimates are 0.46 ± 0.20. For a total dose of 100 mGy, the corresponding
PROFACs are 0.21, 0.23, and 0.54. The average and standard deviation for
these estimates are 0.33 ± 0.19. 
Figure 3 shows the PROFAC decreases as <z1> increases. Three values
for the reference neutrons (0.22- and 0.44-MeV combined data set) are
plotted at PROFAC = 0 and <z1> given by the average of the values for
these radiations (i.e., 87 mGy/hit). However, the three values appear as a
single point. At the dose of 10 mGy, the average hit to NSV would be
10/87 = 0.11. Thus, about 1 in 10 cell nuclei are expected to be hit. The
correlation coefficient for the data in Figure 3 is R = –0.87 ± 0.15 (R2 =
0.76, t = 5.63, degrees of freedom =10, p = 0.00011). Thus, the negative cor-
relation is highly significant and is suggestive of an inhibitory function of
TABLE 5. Gamma-ray protection factors for suppressing neutron-induced micronuclei among
human lymphocytes irradiated in vitro
Gamma-
Ray Protective
Contri- Cells Observed Expected (Hormetic) Gamma-
bution Without Micro- Micro- Effect of Ray
Radiation to the Total Micro- nucleated nucleated Chi Gamma Protection
Dose Dose Cells nuclei Cells Cells Square Rays Factor
Neutrons mGy mGy p-value Implicated PROFAC
Reference 10 0.1 20909 20595 314 314
1.5-MeV 10 0.2 9769 9709 60 147 52 5.478E–13 yes 0.59
5.9-MeV 10 0.6 13730 13631 99 206 57 5.415E–14 yes 0.52
13.7-MeV 10 0.6 9833 9794 39 148 81 2.054E–19 yes 0.74
Reference 50 0.5 20622 20293 329 329
1.5-MeV 50 1 9827 9727 100 157 21 4.85E–06 yes 0.36
5.9-MeV 50 3 12787 12649 138 204 22 3.188E–06 yes 0.32
13.7-MeV 50 3 8150 8110 40 130 63 1.74E–15 yes 0.69
Reference 100 1 21369 20940 429 429
1.5-MeV 100 2 9873 9717 156 198 9.2 0.0024569 yes 0.21
5.9-MeV 100 6 10526 10364 162 211 12 0.0006098 yes 0.23
13.7-MeV 100 6 9997 9904 93 201 59 1.596E–14 yes 0.54
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high values for <z1> (relative to gamma rays where <z1> = 0.64 mGy/hit)
with respect to the protective processes that contribute to gamma-ray
hormesis. The data are in fact consistent with the existence of a hit effec-
tiveness function with respect to the suppression of protective cell signal-
ing associated hormesis. The fact that the results in Figure 3 show an
increased PROFAC in association with a 10-mGy macroscopic absorbed
neutron dose when the NSV hit size (mGy/hit) decreases relative to the
reference neutrons with their particularly high <z1> values (80-94
mGy/hit), implicates a robust protective cellular-community response to
DNA damage stimulated by low-dose gamma radiation. The protective
response is thought to involve selective removal of aberrant cells via pro-
tective apoptosis (Bauer 2007; Portess et al. 2007).
Checking for Additional Evidence for a Hit Size Effectiveness Function
Table 6 shows data for the relative frequency of micronucleated cells
(for one or more MN per cell) evaluated at a fixed 10-mGy absorbed dose
and evaluated relative to 250-kVp X rays. The data are arranged accord-
ing to increasing values for <z1> which is a measure of the size of the radi-
ation hit to NSV. The relative frequency is correlated with <z1> (correla-
tion coefficient R = 0.78; p < 0.02) supporting the existence of a hit-size
effective function for induced chromosomal damage as has been pre-
dicted by Bond et al (Bond et al. 1995; Sondhaus et al. 1996) .
Impact of Reducing the Proton, Neutron, and Ions Contribution to Dose
Skeptics may claim that the reduction in risk associated with increas-
ing the gamma-ray contribution to dose could be explained based on the
FIGURE 3. Gamma-ray protection factors against neutron-induced micronucleated cells plotted as a
function of <z1>. PROFAC = 0 for the reference group (0.22- and 0.44-MeV neutrons combined)
which is plotted (three superimposing data points) at the middle of the range 80-94 mGy/hit for <z1>.
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corresponding reduction in the contribution to dose from protons, neu-
trons, and other ions. An increase in the gamma-ray dose of only 0.1 mGy
was found to be protective for 1.5-MeV neutrons when compared to a ref-
erence group comprised of 0.22- and 0.44-MeV neutrons. For the refer-
ence group the excess frequency of micronucleated cells per unit dose
after 10-mGy exposure was [(314/20,900) – (217/25699)]/10 mGy = 6.58 ×
10–4/mGy. Reducing the proton, neutron, and other ions contribution to
the dose by 0.1 mGy would be expected to decrease the micronucleated
cell frequcncy by 0.1*6.58 × 10–4/mGy = 6.58 × 10–5. The expected reduc-
tion in micronucleated cells among 9,769 irradiated cells would be
9,769*6.58 × 10–5 = 0.64 cells when for the 1.5-MeV neutron exposure
only 60 micronucleated cells were observed as compared to 147 expected
(Table 5). Thus, a 0.1-mGy reduction in the proton, neutron, and ions
contribution to the dose could account for a loss of no more than 0.64 or
approximately 1 micronucleated cell. In contrast, gamma-ray-induced
protective signaling appears to have eliminated essentially all of the miss-
ing (147 – 60 = 87) micronucleated cells.
Research Implications for Low-Dose Biodosimetry and Cancer Risk
Assessment
Our results have important implications for neutron biological
dosimetry and for low-dose risk assessment. For large mammals such as
humans, the gamma-ray contribution to the dose varies over the body.
Thus, a biological-dosimetry-based calibration curve for chromosomal
damage to lymphocytes derived using a fixed gamma-ray contribution to
the dose may be inappropriate for neutron biological dosimetry for
humans. A calibration curve based on averaging dose-responses over the
varying gamma-ray contribution to the dose over the body would seem
more appropriate. This average, however, likely varies for different indi-
TABLE 6. Absolute and relative frequencies for one or more micronuclei per cell for different val-
ues of <z1> and a fixed dose of 10 mGy
Type of Radiation <z1> in mGy/hit Absolute Frequency Relative Frequency
a
Gamma rays (662 keV) 0.64 2.72e–3 0.35
250-kVp X rays 2 7.70e–3 1.0
70-kVp X rays 3.6 5.83e–3 0.76
13.7-MeV neutrons 20 3.97e–3 0.51
5.9-MeV neutrons 54 7.21e–3 0.94
1.5-MeV neutrons 64 6.14e–3 0.80
0.44-MeV neutrons 80 1.57e–2 2.0
0.22-MeV neutrons 94 1.41e–2 1.8
aRelative to 250-kVp X rays
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viduals due to differences in body mass. Exposure geometry differences
can also be important. Body-mass and exposure-geometry-specific aver-
ages would therefore be needed.
For cancer risk assessment for monoenergetic fast neutrons, the
gamma-ray component to the dose appears to be quite important so far
as the occurrence of gamma-ray hormesis. Indeed, differences in the low-
dose RBE for neutrons of differing energies and different energy spectra
may largely relate to differences in the protective gamma-ray component
to the dose (a novel concept). Gamma-ray protection can also arise via
stimulation of immunity against cancer (Liu 2007). The existence of
gamma-ray hormesis during low-dose neutron irradiation does not sup-
port the linear-no-threshold (LNT) hypothesis of radiation-induced dele-
terious stochastic radiobiological effects. For varying body sizes and a
fixed total radiation dose, larger body sizes may be associated with
reduced stochastic effects such as cancer, due to greater gamma-ray pro-
tection than for a smaller body size. 
In summary, our research has demonstrated for the first time gamma-
ray hormesis during low-dose neutron irradiation. This protective effect
may largely be responsible for variation in the RBE of neutrons of differ-
ent energies and for neutrons with different energy spectra when the
total radiation dose is ≤ 100 mGy. The protective effect is thought to
relate to biology (gamma-ray activation of high-fidelity DNA repair and
stimulating of apoptosis of aberrant cells). Thus, the RBE for neutron-
induced stochastic radiobiological effects may not depend only on
physics (e.g., LET and lineal energy spectra) but also on biology (DNA
repair and apoptosis). Stimulation of immune system functioning by low
doses of gamma rays could also impact the low-dose neutron RBE for in
vivo radiobiological effects such as cancer.
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